Clay B. Siegall - May 28, 2021 Form 3 Insider Report for Nurix Therapeutics, Inc. (NRIX)

Role
Director
Signature
/s/ Christine Ring, as Attorney-in-Fact for Clay B. Siegall
Stock symbol
NRIX
Transactions as of
May 28, 2021
Transactions value $
$0
Form type
3
Date filed
6/1/2021, 04:19 PM
Previous filing
May 7, 2021
Next filing
Jun 4, 2021

No securities are beneficially owned.

Remarks:

No securities are beneficially owned.